BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22556352)

  • 1. Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities.
    Arcaini L; Rossi D
    Haematologica; 2012 May; 97(5):638-40. PubMed ID: 22556352
    [No Abstract]   [Full Text] [Related]  

  • 2. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
    Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB deregulation in splenic marginal zone lymphoma.
    Spina V; Rossi D
    Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profile in splenic marginal zone lymphoma.
    Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A
    Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation.
    Fonte E; Agathangelidis A; Reverberi D; Ntoufa S; Scarfò L; Ranghetti P; Cutrona G; Tedeschi A; Xochelli A; Caligaris-Cappio F; Ponzoni M; Belessi C; Davis Z; Piris MA; Oscier D; Ghia P; Stamatopoulos K; Muzio M
    Haematologica; 2015 Nov; 100(11):1460-8. PubMed ID: 26294727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
    Spina V; Rossi D
    Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.
    Li Z; Wang H; Xue L; Shin DM; Roopenian D; Xu W; Qi CF; Sangster MY; Orihuela CJ; Tuomanen E; Rehg JE; Cui X; Zhang Q; Morse HC; Morris SW
    Blood; 2009 Nov; 114(19):4158-68. PubMed ID: 19696203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):371-378. PubMed ID: 29222281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.
    Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D
    Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507
    [No Abstract]   [Full Text] [Related]  

  • 11. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
    Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
    Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation patterns in marginal zone lymphoma.
    Arribas AJ; Bertoni F
    Best Pract Res Clin Haematol; 2017; 30(1-2):24-31. PubMed ID: 28288713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
    Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
    Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
    Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
    Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in molecular genetics pathogenesis of splenic marginal zone lymphoma].
    Yan Y; Yi S; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):348-52. PubMed ID: 27094004
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire.
    Bikos V; Stalika E; Baliakas P; Darzentas N; Davis Z; Traverse-Glehen A; Dagklis A; Kanellis G; Anagnostopoulos A; Tsaftaris A; Ponzoni M; Berger F; Felman P; Ghia P; Papadaki T; Oscier D; Belessi C; Stamatopoulos K
    Leukemia; 2012 Dec; 26(12):2567-9. PubMed ID: 22858907
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.